Why plateaus happen
A weight loss plateau — a period of weeks where the scale does not move despite continued treatment — is a normal and expected part of the weight loss process. It is not a sign that the medication has stopped working.
As body weight decreases, total daily energy expenditure also decreases — a smaller body requires fewer calories to maintain itself. The body also adapts metabolically to a sustained caloric deficit through a process called adaptive thermogenesis, reducing its basal metabolic rate. These are evolutionary survival mechanisms, not failures of willpower or medication.
When to consider a dose increase
If you have been on a stable dose for 8–12 weeks and weight loss has stalled, a dose increase may be appropriate — provided you are tolerating your current dose well and have not yet reached the maximum dose for your medication.
At EVERLean, dose progression decisions are made in clinical review, not automatically. We consider your current dose, side effect history, rate of weight loss to date, and your overall health goals. Some patients achieve excellent results at lower doses and do not benefit from escalation; others need the full therapeutic dose to see meaningful progress.
Clinical Review
Stuck on a plateau? Talk to your doctor
If you have been on a stable dose for 8–12 weeks without progress, a clinical review can identify whether a dose increase, medication switch, or dietary adjustment is the right next step.
Book a Clinical ReviewReviewing diet and activity
A plateau is also a useful prompt to review dietary habits. As appetite suppression becomes familiar, some patients unconsciously return to higher-calorie food choices or larger portions. Tracking food intake for 1–2 weeks — even informally — often reveals patterns that are easy to correct.
Physical activity plays a meaningful role in breaking plateaus. Resistance training in particular helps preserve and build lean muscle mass, which raises resting metabolic rate. Even 2–3 sessions per week of bodyweight exercises or light weights can make a measurable difference over time.
The Open Vault
The Hunger Vault: understand what is really happening
The Hunger Vault helps you distinguish true appetite changes from habit-driven eating — a key skill when you are trying to identify why a plateau has set in and what to do about it.
Open The Hunger VaultSwitching medications
If you have been on semaglutide (Wegovy) at maximum dose for an extended period and weight loss has stalled, switching to tirzepatide (Mounjaro) is a clinically reasonable option. The dual GLP-1/GIP mechanism of tirzepatide can produce additional weight loss in patients who have plateaued on semaglutide alone.
This is not a decision to make unilaterally — your EVERLean doctor will review your full treatment history and advise on whether switching is appropriate and how to manage the transition safely.
The Dispensary
Considering switching to Mounjaro?
If you have plateaued on Wegovy and your doctor recommends switching, Mounjaro is available through EVERLean with transparent per-dose pricing and ongoing clinical support.
View Mounjaro Pricing
